Press release
RNAi Therapeutics Market Worth USD 20.35 Bn by 2030 | Quark Software, Roche, Rexahn, Silence Therapeutics
Global RNAi Therapeutics Market, 2023 - 2030
Request full report sample here: https://www.congruencemarketinsights.com/report/rnai-therapeutics-market?section=Request
What is the anticipated market size in 2030, along with the major drivers, restraints, and opportunities?
According to the in-depth market study, the global RNAi therapeutics market is anticipated to reach a value of USD 20.35 Billion by 2030, expanding at a notable CAGR of 8.4% between 2023 and 2030. The RNAi therapeutics market is primarily driven by advancements in RNA interference (RNAi) technology, increasing prevalence of genetic disorders and chronic diseases, and growing demand for personalized medicine. Opportunities lie in expanding applications of RNAi therapeutics in oncology, neurodegenerative disorders, and infectious diseases, as well as the development of novel RNAi delivery systems. However, challenges include off-target effects and the need for further research to enhance RNAi specificity and efficacy.
How does AI impact the global RNAi Therapeutics market?
AI impacts the global RNAi therapeutics market by facilitating drug discovery and development, optimizing treatment strategies, and accelerating personalized medicine initiatives. AI-driven algorithms analyze vast amounts of genomic and clinical data to identify potential RNAi drug targets and predict therapeutic responses, streamlining the drug discovery process and reducing development timelines. Advanced AI models enable personalized treatment approaches by integrating patient-specific genetic information and clinical data, optimizing treatment regimens and improving patient outcomes. Additionally, AI-powered bioinformatics tools facilitate RNAi off-target prediction and design of RNAi delivery vehicles, enhancing the specificity and efficacy of RNAi therapeutics. While AI integration offers significant benefits, challenges include data privacy concerns and the need for regulatory frameworks to govern AI-driven healthcare solutions effectively.
Buy Now @ https://www.congruencemarketinsights.com/buy-now/241/1
Scope of the Report:
► Executive Summary
► Demand and Supply-side Trends
► Market Drivers, Restraints, Opportunities and Challenges
► Value Chain Analysis
► Porter's Five Forces Analysis
► Industry SWOT Analysis
► COVID-19 Impact Assessment
► PESTLE Analysis
► Global Market Size and Forecast
► Regional Market Size and Forecast (Cross-country Analysis)
► Competition Landscape
► Company Profiles
RNAi Therapeutics Market Size and Forecast:
The report will comprehensively detail the RNAi therapeutics market size and forecast (2023-2030), presenting key metrics for strategic insights. We will analyze market revenue, quantifying total income from RNAi therapeutics sales, and provide volume insights into product circulation. The report will delineate market share, highlighting competitive landscapes. Year-on-Year growth analysis will track annual percentage changes, offering trend insights. Additionally, the Compound Annual Growth Rate (CAGR) will be presented, providing a smoothed growth rate for a more consistent assessment of the market's expansion over the forecast period.
Which region holds the largest market share, and where does the major opportunity lie in the future?
North America holds the largest market share in the global RNAi therapeutics market, driven by a robust biotechnology and pharmaceutical industry, significant investments in genomic medicine, and a high prevalence of genetic disorders and chronic diseases. Major opportunities lie in expanding applications of RNAi therapeutics in precision medicine and developing targeted therapies for rare diseases. Additionally, Europe and Asia Pacific are expected to witness significant growth opportunities due to increasing government initiatives to promote genetic medicine research and development, rising healthcare expenditure, and growing adoption of personalized medicine approaches.
Competition Landscape
The global RNAi therapeutics market is highly competitive, characterized by the presence of established pharmaceutical companies and biotechnology firms, as well as innovative startups focusing on RNAi drug development. Key competitors focus on research and development of novel RNAi therapeutics targeting various disease indications, strategic collaborations, and acquisitions to expand their product portfolios and strengthen their market position. Diverse applications, ranging from genetic disorders to oncology and infectious diseases, contribute to market dynamism. The competition landscape is shaped by a blend of industry incumbents and emerging players, all vying for leadership in this rapidly evolving segment of the biopharmaceutical industry.
>> Quark Software Inc.
>> F. Hoffmann-La Roche Ltd.
>> Rexahn Pharmaceuticals, Inc.
>> Silence Therapeutics
>> Arbutus Biopharma
>> Benitec Biopharma
>> GSK plc
>> OLIX PHARMACEUTICALS, INC.
>> Sanofi
>> Alnylam Pharmaceuticals, Inc.
>> Moderna Inc.
>> Ionis Pharmaceuticals
Comprehensive Market Segmentation:
∆ By Molecule Type (Small Interfering RNAS, Microrna)
∆ By Application (Genetic Disorder, Oncology, Neurodegenerative Disorder, Cardiovascular Disorder, Respiratory Disorder, Infectious Disease, Renal Disease, Other)
∆ By Route of Administration (Intradermal Injections, Pulmonary Delivery, Intravenous Injections, Intraperitoneal Injections, Others)
∆ By End- User (Diagnostic Laboratories, Research and Academic Laboratories, Hospitals)
Market Segmentation by Geography including:
∆ North America: U.S., Canada and Mexico
∆ Europe: Germany, France, U.K., Italy, Spain, and Rest of Europe
∆ Asia Pacific: China, India, Japan, South Korea, Southeast Asia, and Rest of Asia Pacific
∆ South America: Brazil, Argentina, and Rest of Latin America
∆ Middle East & Africa: GCC Countries, South Africa, and Rest of Middle East & Africa
Frequently Asked Questions (FAQs):
► What is the current market scenario?
► What was the historical demand scenario, and forecast outlook from 2023 to 2030?
► What are the key market dynamics influencing growth in the Global RNAi Therapeutics Market?
► Who are the prominent players in the Global RNAi Therapeutics Market?
► What is the consumer perspective in the Global RNAi Therapeutics Market?
► What are the key demand-side and supply-side trends in the Global RNAi Therapeutics Market?
► What are the largest and the fastest growing geographies?
► Which segment dominated and which segment is expected to grow fastest?
► What was the COVID-19 impact on the Global RNAi Therapeutics Market?
Explore in-depth industry research reports across various verticals from Congruence Market Insights @ https://www.congruencemarketinsights.com/reports/all-industries
Related Reports;
► Long Read Sequencing Market: https://www.congruencemarketinsights.com/report/long-read-sequencing-market
► DNA Nanotechnology Market: https://www.congruencemarketinsights.com/report/dna-nanotechnology-market
Contact Us:
Ms. Shalaka Dubey
Senior Sales Manager
Congruence Market Insights
Palo Alto, CA 94301, United States
Phone: +1 650-646-2623
Email: sales@congruencemarketinsights.com
About Us:
Congruence Market Insights is a leading market research firm dedicated to providing in-depth analysis and strategic solutions for businesses across diverse industries. With a focus on delivering actionable insights, we offer comprehensive market intelligence, trend analysis, and forecasting to empower informed decision-making. We have built a reputation for delivering practical insights and genuine reports across diverse sectors such as biotechnology, pharmaceuticals, healthcare, technology, and more, covering an extensive array of both primary and niche sub-domains. Our expertise lies in uncovering market trends, consumer behavior, and competitive landscapes, enabling our clients to stay ahead in an ever-evolving business landscape.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNAi Therapeutics Market Worth USD 20.35 Bn by 2030 | Quark Software, Roche, Rexahn, Silence Therapeutics here
News-ID: 3392470 • Views: …
More Releases from Congruence Market Insights
Edge AI Software Market Brief Exploration to 2031: Growth Analysis, CAGR Status, …
The recently published Edge AI Software Market Report 2024, spanning 169 pages, offers a comprehensive overview of the market's current state, size, volume, and market share. In today's rapidly evolving business landscape, staying informed about the Edge AI Software Market is essential for businesses and marketers alike.
This report is a valuable resource for gaining insights through in-depth research and analysis. It goes beyond mere data and statistics, serving as…
Directed Energy Weapons Market New Update: Latest Trends, Dynamics, Upcoming Opp …
The recently published Directed Energy Weapons Market Report 2024, spanning 185 pages, offers a comprehensive overview of the market's current state, size, volume, and market share. In today's rapidly evolving business landscape, staying informed about the Directed Energy Weapons Market is essential for businesses and marketers alike. This report is a valuable resource for gaining insights through in-depth research and analysis. It goes beyond mere data and statistics, serving as…
Educational Toys Market Brief Exploration to 2031: Growth Analysis, CAGR Status, …
The recently published Educational Toys Market Report 2024, spanning 251 pages, offers a comprehensive overview of the market's current state, size, volume, and market share. In today's rapidly evolving business landscape, staying informed about the Educational Toys Market is essential for businesses and marketers alike. This report is a valuable resource for gaining insights through in-depth research and analysis. It goes beyond mere data and statistics, serving as a strategic…
Cement Board Market New Update: Latest Trends, Dynamics, Upcoming Opportunities …
The recently published Cement Board Market Report 2024, spanning 235 pages, offers a comprehensive overview of the market's current state, size, volume, and market share. In today's rapidly evolving business landscape, staying informed about the Cement Board Market is essential for businesses and marketers alike. This report is a valuable resource for gaining insights through in-depth research and analysis. It goes beyond mere data and statistics, serving as a strategic…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
